Expression data of whole genome from new diagnostic AML patients (with or without EMI) and healthy volunteers. Expression data of whole genome from new diagnostic AML patients (with or without EMI) and healthy volunteers

Whole Genome microarray was conducted to further explore the underlying gene expression alterations in extramedullary infiltration (EMI) of AML. 4 matched samples from EMI, non-EMI AML patients and healthy volunteers were selected. Mononuclear cells from 12 bone marrow samples were separated according to protocols. RNA was then extracted and hybridization for further microarray analysis. Overall design: EMI-related genes were selected by comparing with non-EMI AML patients and healthy controls. 4 independent experiments were performed using different donors for each experiment.